Amyris Inc. [NASDAQ: AMRS] loss -4.35% or -0.15 points to close at $3.30 with a heavy trading volume of 2713851 shares. The company report on August 14, 2020 that Amyris Appoints Sheila Shekar Pollak As Chief Marketing Officer Of Biossance.
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the appointment of Sheila Shekar Pollak as Chief Marketing Officer of its Biossance™ Clean Beauty skincare brand. Sheila has a proven track record in developing and executing world-class brand and marketing strategies that deliver high growth consumer brands.
Most recently, Sheila was the Chief Marketing Officer of Athleta, a subsidiary of Gap, Inc., one of the fastest-growing women’s apparel brands in the United States. Since joining in 2011, she played an integral role in defining and bringing to life Athleta’s mission to ignite a community of active, healthy, confident women and girls who empower one another to realize their limitless potential. She spearheaded the company’s Power of She platform, launched the Athleta Girl brand, led Athleta in becoming a B Corp (corporations that balance purpose and profit) and changed the future of female athlete sponsorships by signing on the most highly decorated track and field athlete, Allyson Felix. Prior to Athleta, she held global marketing leadership roles at Gap and Banana Republic. Sheila was recently honored as one of the 2020 AdWeek Women’s Trailblazer Award winners and Brand Innovators’ Top 100 Women in Brand Marketing. .
It opened the trading session at $3.43, the shares rose to $3.44 and dropped to $3.10, the range by which the price of stock traded the whole day. The daily chart for AMRS points out that the company has recorded 5.43% gains over the past six months. However, it is still -135.71% lower than its most recent low trading price.
If we look at the average trading volume of 2.70M shares, AMRS reached to a volume of 2713851 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Amyris Inc. [AMRS]:
Oppenheimer have made an estimate for Amyris Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on December 12, 2019. While these analysts kept the previous recommendation, B. Riley FBR raised their target price from $10 to $8. The new note on the price target was released on November 14, 2018, representing the official price target for Amyris Inc. stock. Previously, the target price had yet another raise to $8, while B. Riley FBR Inc. analysts kept a Buy rating on AMRS stock.
The Average True Range (ATR) for Amyris Inc. is set at 0.28, with the Price to Sales ratio for AMRS stock in the period of the last 12 months amounting to 5.12.
Trading performance analysis for AMRS stock
Amyris Inc. [AMRS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.52. With this latest performance, AMRS shares dropped by -27.31% in over the last four-week period, additionally plugging by 5.43% over the last 6 months – not to mention a drop of -16.88% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMRS stock in for the last two-week period is set at 36.00, with the RSI for the last a single of trading hit 32.28, and the three-weeks RSI is set at 39.81 for Amyris Inc. [AMRS]. The present Moving Average for the last 50 days of trading for this stock 4.12, while it was recorded at 3.44 for the last single week of trading, and 3.41 for the last 200 days.
Amyris Inc. [AMRS]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Amyris Inc. [AMRS] shares currently have an operating margin of -79.76 and a Gross Margin at +50.06. Amyris Inc.’s Net Margin is presently recorded at -154.29.
Additionally, AMRS Total Debt to Total Capital is recorded at 754.98, with Total Debt to Total Assets ending up at 179.58.
Reflecting on the efficiency of the workforce at the company, Amyris Inc. [AMRS] managed to generate an average of -$419,585 per employee. Receivables Turnover for the company is 5.64 with a Total Asset Turnover recorded at a value of 1.06.Amyris Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.20 and a Current Ratio set at 1.50.
Amyris Inc. [AMRS]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Amyris Inc. posted -0.51/share EPS, while the average EPS was predicted by analysts to be reported at -0.53/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 3.80%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMRS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Amyris Inc. go to 30.00%.
An analysis of insider ownership at Amyris Inc. [AMRS]
There are presently around $256 million, or 42.40% of AMRS stock, in the hands of institutional investors. The top three institutional holders of AMRS stocks are: FMR LLC with ownership of 17,890,536, which is approximately 7.965% of the company’s market cap and around 0.70% of the total institutional ownership; VIVO CAPITAL, LLC, holding 10,181,472 shares of the stock with an approximate value of $33.6 million in AMRS stocks shares; and FARALLON CAPITAL MANAGEMENT LLC, currently with $23.13 million in AMRS stock with ownership of nearly New of the company’s market capitalization.
Positions in Amyris Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 75 institutional holders increased their position in Amyris Inc. [NASDAQ:AMRS] by around 33,972,131 shares. Additionally, 35 investors decreased positions by around 4,316,003 shares, while 19 investors held positions by with 39,138,272 shares. The mentioned changes placed institutional holdings at 77,426,406 shares, according to the latest SEC report filing. AMRS stock had 31 new institutional investments in for a total of 22,703,749 shares, while 12 institutional investors sold positions of 1,194,139 shares during the same period.